UAE Over the Counter (OTC) Drugs Market, By Product Type (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027
UAE Over the Counter (OTC) Drugs Market stood at USD552.11 million in 2021 and is expected to reach a CAGR of 5.49% during the forecast period. The rise in both communicable and non-communicable diseases, as well as the emergence of new viral diseases, is increasing the demand for self-medication, focusing more on the prevention of the disease at home. Self-medication and OTC drug use have substantially increased over the past few decades in both women and men due to the rising cost of healthcare globally. This rise in OTC usage may be ascribed to pharmaceutical companies' representatives' promotion of drugs through commercials and other social media channels. Examples of strategies used to expand market penetration for OTC drugs include financial incentives like rewards for taking part in post-marketing trials, the distribution of free samples, or the supply of OTC drugs at deeply discounted prices to hospitals. Additionally, advertising typically appears in printed periodicals like journals, magazines, and newspapers, as well as in broadcast media like radio, television, and telephone systems. Consumers are putting more emphasis on prevention and taking an active role in their healthcare decisions. This is due to continuous fears about catching COVID-19 and other emerging diseases, as well as the realization that those who lead balanced lives will do better in the long run. The COVID-19 epidemic has expedited the shift in lifestyle toward self-care. All citizens of the United Arab Emirates (UAE) are entitled to free medical care and prescription drugs; however, expatriates are only needed to purchase private health insurance. In the UAE, general practitioners' visits, routine and specialized health exams, and prescription medications are expensive. Studies have indicated that OTC use is common in the UAE, particularly for individuals without medical insurance, as a result of the high expenses there. Additionally, the growth of the aging population in the country and more demand for self-medication for common diseases and diagnosed diseases that can be treated at home rather than hospitalization to cut off expenses will enhance the growth of the UAE over the counter (OTC) drugs market.
E-Pharmacy's Growth and the New Digital Shopper
The COVID-19 pandemic has significantly sped up the transition to E-commerce, and E-Pharmacy has cemented its position as a key element of the omnichannel retail environment for consumer health. The need for pharmacy home delivery has been expanding in the UAE. However, the COVID-19 outbreak has forced people to stay away from shopping malls and other general and retail stores, which has significantly increased the demand. The majority of individuals today prefer to order their OTC and personal care items online than going out and buy them, with smartphone penetration having one of the highest rates internationally. Pharmacy websites provide a secure and convenient way to buy important medical goods.
In the upcoming years, it is anticipated that these changes in consumer purchasing patterns would persist, making E-Commerce a primary rather than a secondary channel for consumer health businesses. A successful strategy in E-Pharmacy can be found in the use of digital automation and machine learning to evaluate consumer behavior and give tailored advertising and product recommendations based on prior purchases, comparable consumer behaviors, and online purchasing behaviors. Thus, the availability of the OTC drugs which can be accessed without the need of any prescription is becoming more convenient for people to purchase it from the online stores.
Change in Regulatory Landscape
With the assistance of patient organizations, healthcare professionals, public health organizations, and pharmaceutical business, the Gulf Cooperation Council (GCC) nations (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates) are aiming to evaluate and update pharmacy regulations for over-the-counter medicines. In order to serve patients, consumers, and businesses, OTC regulations are being updated. These changes aim to streamline and improve the timeliness of procedures, encourage consumer innovation, and, in some cases, build up domestic manufacturing capacity to lessen reliance on imports. The health authorities support making OTC products more widely available in the region. Specific dispensing standards have been established as part of the oversight of the market to ensure the effectiveness and safety of OTC drugs. The availability of more OTC products increases both customer choice and business potential for retailers and consumer health organizations.
Increase in OTC Drugs Launch in Gulf Cooperation Council
Companies in the consumer health sector is adapting in shifting consumer preferences, competition, altering consumer behavior, and technological advancements. These factors all require companies to invest in new products in order to succeed or survive, while also addressing both internal and external corporate challenges. Over the past three years, innovation's share of the GCC's OTC market has grown, reaching 18.5 percent in November 2021. To increase sales and earnings, the sector needs disruptive innovation techniques. Contrary to other regions, the GCC countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates) have historically had a low R&D intensity, but they are presently making efforts to change that. By investing in R&D and enhancing the production capacity of drugs the growth in the demand for OTC drugs is expected to increase by time.
Growth of Private Label Retail Brands
In particular, in categories like VMS (Vitamins, Mineral, and Supplements), dermo-cosmetics, and personal care goods, the rise of private label (store brands) and the elimination of slower-moving branded products are altering the pharmacy shopping experience, leading to competition for in-store shelf space and margins. It's now becoming more difficult to compete with private-label brands because of their increasing demand among the population. Consumer health organizations are rising to the challenge by creating category strategies that take into account the importance of private label and their brands, being innovative to meet current needs and shifts in consumer behavior, and putting an emphasis on enhancing the brand's perceived superiority through consistent brand equity investment and wise innovation to compete. Until a balance is found, private brands will develop and occupy more shelf space because of the lack of effectiveness people assume in non-branded OTC drugs. The UAE, which imports 80% of its pharmaceutical products, has been investing in reducing costs and ensuring steady supplies by heavily boosting its local manufacturing capabilities.
Market Segmentation
The UAE Over the Counter (OTC) Drugs Market is segmented based on Product type, Route of Administration, Dosage Form, Distribution Channel and Region. Based on Product type, the market can be categorized into Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others (Antibiotics, Antifungal, Laxatives etc.). Based on Route of Administration, the market can be categorized into Oral, Topical, Parenteral. In terms of Dosage Form, the market can be segmented into Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others (Sprays, Powders, Gels, Paste etc.). Based on Distribution Channel the market can be segmented into Retail Pharmacy, Hospital Pharmacy, E-Pharmacy.
Company Profiles
Bayer Consumer Health, Novartis Middle East, GlaxoSmithKline & Neopharma, Sun Pharma Global FZE, Johnson & Johnson Middle East, Julphar Gulf Pharmaceutical Industries, Cipla FZE, Pfizer Inc., Galderma SA, Sanofi UAE are the major players in the UAE OTC Drugs market.
Report Scope:
In this report, UAE Over the Counter (OTC) Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in UAE over the counter (OTC) drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
E-Pharmacy's Growth and the New Digital Shopper
The COVID-19 pandemic has significantly sped up the transition to E-commerce, and E-Pharmacy has cemented its position as a key element of the omnichannel retail environment for consumer health. The need for pharmacy home delivery has been expanding in the UAE. However, the COVID-19 outbreak has forced people to stay away from shopping malls and other general and retail stores, which has significantly increased the demand. The majority of individuals today prefer to order their OTC and personal care items online than going out and buy them, with smartphone penetration having one of the highest rates internationally. Pharmacy websites provide a secure and convenient way to buy important medical goods.
In the upcoming years, it is anticipated that these changes in consumer purchasing patterns would persist, making E-Commerce a primary rather than a secondary channel for consumer health businesses. A successful strategy in E-Pharmacy can be found in the use of digital automation and machine learning to evaluate consumer behavior and give tailored advertising and product recommendations based on prior purchases, comparable consumer behaviors, and online purchasing behaviors. Thus, the availability of the OTC drugs which can be accessed without the need of any prescription is becoming more convenient for people to purchase it from the online stores.
Change in Regulatory Landscape
With the assistance of patient organizations, healthcare professionals, public health organizations, and pharmaceutical business, the Gulf Cooperation Council (GCC) nations (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates) are aiming to evaluate and update pharmacy regulations for over-the-counter medicines. In order to serve patients, consumers, and businesses, OTC regulations are being updated. These changes aim to streamline and improve the timeliness of procedures, encourage consumer innovation, and, in some cases, build up domestic manufacturing capacity to lessen reliance on imports. The health authorities support making OTC products more widely available in the region. Specific dispensing standards have been established as part of the oversight of the market to ensure the effectiveness and safety of OTC drugs. The availability of more OTC products increases both customer choice and business potential for retailers and consumer health organizations.
Increase in OTC Drugs Launch in Gulf Cooperation Council
Companies in the consumer health sector is adapting in shifting consumer preferences, competition, altering consumer behavior, and technological advancements. These factors all require companies to invest in new products in order to succeed or survive, while also addressing both internal and external corporate challenges. Over the past three years, innovation's share of the GCC's OTC market has grown, reaching 18.5 percent in November 2021. To increase sales and earnings, the sector needs disruptive innovation techniques. Contrary to other regions, the GCC countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates) have historically had a low R&D intensity, but they are presently making efforts to change that. By investing in R&D and enhancing the production capacity of drugs the growth in the demand for OTC drugs is expected to increase by time.
Growth of Private Label Retail Brands
In particular, in categories like VMS (Vitamins, Mineral, and Supplements), dermo-cosmetics, and personal care goods, the rise of private label (store brands) and the elimination of slower-moving branded products are altering the pharmacy shopping experience, leading to competition for in-store shelf space and margins. It's now becoming more difficult to compete with private-label brands because of their increasing demand among the population. Consumer health organizations are rising to the challenge by creating category strategies that take into account the importance of private label and their brands, being innovative to meet current needs and shifts in consumer behavior, and putting an emphasis on enhancing the brand's perceived superiority through consistent brand equity investment and wise innovation to compete. Until a balance is found, private brands will develop and occupy more shelf space because of the lack of effectiveness people assume in non-branded OTC drugs. The UAE, which imports 80% of its pharmaceutical products, has been investing in reducing costs and ensuring steady supplies by heavily boosting its local manufacturing capabilities.
Market Segmentation
The UAE Over the Counter (OTC) Drugs Market is segmented based on Product type, Route of Administration, Dosage Form, Distribution Channel and Region. Based on Product type, the market can be categorized into Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others (Antibiotics, Antifungal, Laxatives etc.). Based on Route of Administration, the market can be categorized into Oral, Topical, Parenteral. In terms of Dosage Form, the market can be segmented into Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others (Sprays, Powders, Gels, Paste etc.). Based on Distribution Channel the market can be segmented into Retail Pharmacy, Hospital Pharmacy, E-Pharmacy.
Company Profiles
Bayer Consumer Health, Novartis Middle East, GlaxoSmithKline & Neopharma, Sun Pharma Global FZE, Johnson & Johnson Middle East, Julphar Gulf Pharmaceutical Industries, Cipla FZE, Pfizer Inc., Galderma SA, Sanofi UAE are the major players in the UAE OTC Drugs market.
Report Scope:
In this report, UAE Over the Counter (OTC) Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- UAE Over the Counter (OTC) Drugs Market, By Product Type:
- Cough, Cold and Flu
- Vitamins, Mineral, and Supplements (VMS)
- Analgesics
- Gastrointestinal Products
- Dermatology Products
- Others
- UAE Over the Counter (OTC) Drugs Market, By Route of Administration:
- Oral
- Topical
- Parenteral
- UAE Over the Counter (OTC) Drugs Market, By Dosage Form:
- Tablets
- Capsules
- Liquids & Solution
- Creams/Lotions/Ointments
- Others
- UAE Over the Counter (OTC) Drugs Market, By Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- E-Pharmacy
- UAE Over the Counter (OTC) Drugs Market, By Region:
- Dubai
- Abu Dhabi
- Sharjah
Company Profiles: Detailed analysis of the major companies present in UAE over the counter (OTC) drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. IMPACT OF COVID-19 ON UAE OVER THE COUNTER (OTC) DRUGS MARKET
5. VOICE OF CUSTOMER
5.1. Brand Awareness
5.2. Factors affecting Choice of Over the Counter (OTC) drugs
5.3. Preference among population, By Product Type
6. UAE OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. UAE COUGH, COLD AND FLU OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
8. UAE VITAMINS, MINERAL AND SUPPLEMENTS (VMS) OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Route of Administration
8.2.2. By Dosage Form
8.2.3. By Distribution Channel
9. UAE ANALGESICS OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Route of Administration
9.2.2. By Dosage Form
9.2.3. By Distribution Channel
10. UAE GASTROINTESTINAL OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Route of Administration
10.2.2. By Dosage Form
10.2.3. By Distribution Channel
11. UAE DERMATOLOGY OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Route of Administration
11.2.2. By Dosage Form
11.2.3. By Distribution Channel
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. POLICY & REGULATORY LANDSCAPE
15. UAE ECONOMIC PROFILE
16. COMPETITIVE LANDSCAPE
16.1. Competition Outlook
16.2. Company Profiles
16.2.1. Bayer Consumer Health
16.2.2. Novartis Middle East
16.2.3. GlaxoSmithKline & Neopharma
16.2.4. Sun Pharma Global FZE
16.2.5. Johnson & Johnson Middle East
16.2.6. Julphar Gulf Pharmaceutical Industries
16.2.7. Cipla FZE
16.2.8. Pfizer Inc.
16.2.9. Galderma SA
16.2.10. Sanofi UAE
17. STRATEGIC RECOMMENDATIONS
(Note: The companies list can be customized based on the client requirements.)
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. IMPACT OF COVID-19 ON UAE OVER THE COUNTER (OTC) DRUGS MARKET
5. VOICE OF CUSTOMER
5.1. Brand Awareness
5.2. Factors affecting Choice of Over the Counter (OTC) drugs
5.3. Preference among population, By Product Type
6. UAE OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. UAE COUGH, COLD AND FLU OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
8. UAE VITAMINS, MINERAL AND SUPPLEMENTS (VMS) OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Route of Administration
8.2.2. By Dosage Form
8.2.3. By Distribution Channel
9. UAE ANALGESICS OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Route of Administration
9.2.2. By Dosage Form
9.2.3. By Distribution Channel
10. UAE GASTROINTESTINAL OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Route of Administration
10.2.2. By Dosage Form
10.2.3. By Distribution Channel
11. UAE DERMATOLOGY OVER THE COUNTER (OTC) DRUGS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Route of Administration
11.2.2. By Dosage Form
11.2.3. By Distribution Channel
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. POLICY & REGULATORY LANDSCAPE
15. UAE ECONOMIC PROFILE
16. COMPETITIVE LANDSCAPE
16.1. Competition Outlook
16.2. Company Profiles
16.2.1. Bayer Consumer Health
16.2.2. Novartis Middle East
16.2.3. GlaxoSmithKline & Neopharma
16.2.4. Sun Pharma Global FZE
16.2.5. Johnson & Johnson Middle East
16.2.6. Julphar Gulf Pharmaceutical Industries
16.2.7. Cipla FZE
16.2.8. Pfizer Inc.
16.2.9. Galderma SA
16.2.10. Sanofi UAE
17. STRATEGIC RECOMMENDATIONS
(Note: The companies list can be customized based on the client requirements.)
LIST OF FIGURES
Figure 1: UAE Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 2: UAE Over the Counter (OTC) Drugs Market Share, By Product Type, By Value, 2017-2027F
Figure 3: UAE Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 4: UAE Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 5: UAE Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 6: UAE Over the Counter (OTC) Drugs Market Share, By Region, By Value, 2017-2027F
Figure 7: UAE Over the Counter (OTC) Drugs Market Share, By Company, By Value, 2021
Figure 8: UAE Over the Counter (OTC) Drugs Market Map, By Product Type, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: UAE Over the Counter (OTC) Drugs Market Map, By Route of Administration, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: UAE Over the Counter (OTC) Drugs Market Map, By Dosage Form, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: UAE Over the Counter (OTC) Drugs Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: UAE Over the Counter (OTC) Drugs Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: UAE Cough, Cold and Flu Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 14: UAE Cough, Cold and Flu Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 15: UAE Cough, Cold and Flu Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 16: UAE Cough, Cold and Flu Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 17: UAE Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 18: UAE Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 19: UAE Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 20: UAE Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 21: UAE Analgesics Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 22: UAE Analgesics Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 23: UAE Analgesics Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 24: UAE Analgesics Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 25: UAE Gastrointestinal Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 26: UAE Gastrointestinal Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 27: UAE Gastrointestinal Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 28: UAE Gastrointestinal Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 29: UAE Dermatology Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 30: UAE Dermatology Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 31: UAE Dermatology Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 32: UAE Dermatology Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 1: UAE Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 2: UAE Over the Counter (OTC) Drugs Market Share, By Product Type, By Value, 2017-2027F
Figure 3: UAE Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 4: UAE Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 5: UAE Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 6: UAE Over the Counter (OTC) Drugs Market Share, By Region, By Value, 2017-2027F
Figure 7: UAE Over the Counter (OTC) Drugs Market Share, By Company, By Value, 2021
Figure 8: UAE Over the Counter (OTC) Drugs Market Map, By Product Type, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: UAE Over the Counter (OTC) Drugs Market Map, By Route of Administration, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: UAE Over the Counter (OTC) Drugs Market Map, By Dosage Form, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: UAE Over the Counter (OTC) Drugs Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
Figure 12: UAE Over the Counter (OTC) Drugs Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 13: UAE Cough, Cold and Flu Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 14: UAE Cough, Cold and Flu Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 15: UAE Cough, Cold and Flu Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 16: UAE Cough, Cold and Flu Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 17: UAE Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 18: UAE Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 19: UAE Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 20: UAE Vitamins, Mineral and Supplements (VMS) Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 21: UAE Analgesics Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 22: UAE Analgesics Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 23: UAE Analgesics Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 24: UAE Analgesics Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 25: UAE Gastrointestinal Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 26: UAE Gastrointestinal Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 27: UAE Gastrointestinal Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 28: UAE Gastrointestinal Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 29: UAE Dermatology Over the Counter (OTC) Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 30: UAE Dermatology Over the Counter (OTC) Drugs Market Share, By Route of Administration, By Value, 2017-2027F
Figure 31: UAE Dermatology Over the Counter (OTC) Drugs Market Share, By Dosage Form, By Value, 2017-2027F
Figure 32: UAE Dermatology Over the Counter (OTC) Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
